Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter of 2025 after the close of market on Tuesday...